⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15323346 | 0.65 | CHRNA1 (0.30) | — | |
| SCHEMBL5229119 | 0.62 | — | — | |
| SCHEMBL17159951 | 0.57 | ALDH1A1 (0.55) | — | |
| SCHEMBL3907210 | 0.57 | ALDH1A1 (0.31) | — | |
| SCHEMBL2927541 | 0.55 | — | — | |
| SCHEMBL13811987 | 0.55 | — | — | |
| SCHEMBL37950 | 0.53 | MEN1 (0.35) | — | |
| SCHEMBL30753848 | 0.53 | CDC25B (0.33) | — | |
| SCHEMBL31511817 | 0.53 | S100A4 (0.54) | — | |
| SCHEMBL14380284 | 0.52 | ALDH1A1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 723 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612411-B1 | Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins | INSTITUT PASTEUR (FR) | 2026-04-28 | — | — | US | claimed |
| US-20260077068-A1 | ATP-INDEPENDENT BIOLUMINESCENT REPORTER VARIANTS TO IMPROVE IN VIVO IMAGING | UNIV VIRGINIA PATENT FOUNDATION (US) | 2026-03-19 | — | — | US | claimed |
| US-20260000766-A1 | ULTRASOUND OPTOGENETIC COMPOSITIONS AND METHODS | UNIV TEXAS (US) | 2026-01-01 | — | — | US | claimed |
| US-20250327807-A1 | NON-RADIOACTIVE CYTOTOXICITY ASSAYS | UNIV SOUTHERN CALIFORNIA (US) | 2025-10-23 | — | — | US | claimed |
| EP-4596707-A2 | NON-RADIOACTIVE CYTOTOXICITY ASSAYS | University of Southern California (US) | 2025-08-06 | — | — | EP | claimed |
| WO-2025122626-A1 | HYDROGEN-BONDED FRAMEWORKS NANOPARTICLES FOR SONO-OPTOGENETIC TREATMENT OF BRAIN DISEASES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-06-12 | — | — | WO | claimed |
| EP-3516068-B1 | NON-RADIOACTIVE CYTOTOXICITY ASSAYS | UNIV SOUTHERN CALIFORNIA (US) | 2025-04-23 | — | — | EP | claimed |
| US-12196759-B2 | Non-radioactive cytotoxicity assays | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2025-01-14 | — | — | US | claimed |
| US-20240230646-A9 | HIGHLY SENSITIVE AND SPECIFIC LUCIFERASE BASED REPORTER ASSAY FOR ANTIGEN DETECTION | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-07-11 | — | — | US | claimed |
| US-20240133885-A1 | HIGHLY SENSITIVE AND SPECIFIC LUCIFERASE BASED REPORTER ASSAY FOR ANTIGEN DETECTION | UNIV SOUTHERN CALIFORNIA (US) | 2024-04-25 | — | — | US | claimed |
| EP-1292580-A1 | PYRAZINE AND IMIDAZOPYRAZINE DERIVATIVES AS ANTIOXIDANTS | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2003-03-19 | — | — | EP | claimed |
| JP-2002519373-A | — | — | 2002-07-02 | — | — | JP | claimed |
| WO-2001087853-A1 | ARYL-SUBSTITUTED N,N-HETEROCYCLIC COMPOUNDS, METHOD FOR THEIR PREPARATION AND THEIR USE IN THERAPEUTICS AND DIAGNOSTICS | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2001-11-22 | — | — | WO | claimed |
| EP-1124553-A1 | NEW USE OF GLUTAMATE ANTAGONISTS FOR THE TREATMENT OF CANCER | Ikonomidou, Hrissanthi (DE) | 2001-08-22 | — | — | EP | claimed |
| EP-1100504-A2 | PHARMACEUTICAL COMPOSITIONS AND THEIR USES FOR TREATMENT OF DEMYELINATING DISORDERS | Eisai Co., Ltd. (JP) | 2001-05-23 | — | — | EP | claimed |
| EP-1002535-A1 | New use of glutamate antagonists for the treatment of cancer | Ikonomidou, Hrissanthi (DE) | 2000-05-24 | — | — | EP | claimed |
| WO-2000024395-A1 | NEW USE OF GLUTAMATE ANTAGONISTS FOR THE TREATMENT OF CANCER | IKONOMIDOU HRISSANTHI (DE) | 2000-05-04 | — | — | WO | claimed |
| WO-2000001376-A2 | PHARMACEUTICAL COMPOSITIONS AND THEIR USES FOR TREATMENT OF DEMYELINATING DISORDERS | EISAI CO., LTD (JP) | 2000-01-13 | — | — | WO | claimed |
| US-5736412-A | COMBINATORIAL APPROACH; OPTIMIZING ABILITY FOR COMPOUNDS TO BIND AT REACTION SITE BY SELECTING COMPOUNDS HAVING GREATEST REACTIVITY | ARQULE, INC. (US) | 1998-04-07 | — | — | US | claimed |
| US-5712171-A | DRUGS WITH PEPTIDE GROUPS FOR BEADS, PLATES MEMBRANES AND COMPOSITES | ARQULE, INC. (US) | 1998-01-27 | — | — | US | claimed |